Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9010958 | 0.89 | CYP4F2 (0.33) | — | |
| SCHEMBL22441539 | 0.80 | CPB2 (0.34) | — | |
| SCHEMBL7825176 | 0.78 | CYP2C19 (0.50) | CYP2C19 | |
| SCHEMBL29352013 | 0.78 | SLC6A4 (0.33) | CYP2C19 | |
| SCHEMBL873448 | 0.78 | CYP2C19 (0.32) | CYP2C19 | |
| SCHEMBL2419343 | 0.78 | CYP2C19 (0.32) | CYP2C19 | |
| SCHEMBL29988018 | 0.78 | CYP2C19 (0.32) | CYP2C19 | |
| SCHEMBL11741874 | 0.77 | CYP2C19 (0.31) | CYP2C19 | |
| SCHEMBL11741871 | 0.77 | CYP2C19 (0.31) | CYP2C19 | |
| SCHEMBL11741880 | 0.77 | CYP2C19 (0.31) | CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230295220-A1 | C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | VIIV HEALTHCARE UK NO 5 LTD (GB) | 2023-09-21 | — | — | US | disclosed |
| EP-0477983-B1 | Unsaturated polylactone acrylates and derivatives thereof | UNION CARBIDE CHEM PLASTIC (US) | 1996-11-13 | — | — | EP | disclosed |
| EP-0477983-A2 | Unsaturated polylactone acrylates and derivatives thereof | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY, INC. (US) | 1992-04-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230295220-A1 | C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | IL17A, BET1, CD4 | CYP2C19 172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.